(Q36053876)

English

Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin system

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin system (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

C Buchwalder-Csajka

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

T Buclin

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

H R Brunner

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

J Biollaz

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

48

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

594-604

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Evaluation of noninvasive blood pressure recording by photoplethysmography in clinical studies using angiotensin challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

2 October 2017

Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

2 October 2017

Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

2 October 2017

Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. An overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

2 October 2017

Dose-response relationships of ACE inhibitors and angiotensin II blockers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

2 October 2017

Saralasin in human hypertension: the early experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

2 October 2017

A specific orally active inhibitor of angiotensin-converting enzyme in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

2 October 2017

Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

11 July 2018

RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

11 July 2018

The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

11 July 2018

Noninvasive blood pressure monitoring at the finger for studying short lasting pressor responses in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

11 July 2018

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

11 July 2018

The intellectual health of clinical drug evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

11 July 2018

Clinical Pharmacodynamic Studies with Cilazapril and a Combination of Cilazapril and Propranolol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

11 July 2018

The description and prediction of antihypertensive drug response: an individualised approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

11 July 2018

The contribution of clinical pharmacology surrogates and models to drug development--a critical appraisal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

23 September 2018

Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014379

23 September 2018

SC-52458, an Orally Active Angiotensin II-Receptor Antagonist: Inhibition of Blood Pressure Response to Angiotensin II Challenges and Pharmacokinetics in Normal Volunteers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00050.X

21 January 2018

Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II receptor antagonists - antihypertensive agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic-dynamic relations and individual responses to enalapril

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and hormonal effects of the new angiotensin II receptor antagonist LRB081

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the angiotensin II receptor antagonist, TCV-116, on blood pressure and the renin-angiotensin system in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duration of Action and Short-Term Hormonal Responses to Enalapril (MK 421) in Normal Subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does pharmacological profiling of a new drug in normotensive volunteers provide a useful guideline to antihypertensive therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10583031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2125.1999.00050.X

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36053876&oldid=2143965907"